Medicine Buffalo2mon
Investigational New Drug (IND)
An Investigational New Drug (IND) is a drug or biological drug that has not been ... can each be contacted using the designated Pre-IND Consultation List (PDF - 19KB). Animal study data and toxicity ...
Sierra Sun Times9d
U.S. Senators Introduce Bill to Protect Animals from Unnecessary Drug Testing at the FDA
In 2022, Congress passed the FDAMA 2.0, which Kennedy helped introduce and Pres. Joe Biden signed into law. The law removes a ...
Morningstar2mon
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
("Medicus" or the "Company") is pleased to announce that its Investigational New Animal Drug (INAD File No.013880) has received Minor Use in Major Species Designation (“MUMS”) from the U.S ...
Business Wire1mon
Epirium Bio Announces FDA Clearance of Investigational New Drug Application for MF-300 and Appointment of Alex Casdin as New Chief Executive Officer and Russell Cox as ...
The U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND ... muscle in preclinical studies of healthy animals. In humans and rodents, 15-PGDH gene ...
Hosted on MSN1mon
Bill to push FDA to drop animal testing requirements passes U.S. Senate
the Senator indicated that President Joe Biden signed the FDA Modernization Act 2.0 into law to eliminate a longstanding requirement for investigational new drugs to undergo mandatory animal ...
Morningstar6d
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
Yahoo Finance7d
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate a clinical study of the company’s investigational UKidney ...